Related references
Note: Only part of the references are listed.High variability in baseline urinary free cortisol values in patients with Cushing's disease
S. Petersenn et al.
CLINICAL ENDOCRINOLOGY (2014)
Cushing's syndrome: a structured short-and long-term management plan for patients in remission
Oskar Ragnarsson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists
R. van der Pas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Macrocorticotropinoma shrinkage and control of hypercortisolism under long-term cabergoline therapy: case report
Marcos Paulo Manavela et al.
Pituitary (2011)
Cabergoline monotherapy in the long-term treatment of Cushing's disease
Ariane Godbout et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
High Prevalence of Normal Tests Assessing Hypercortisolism in Subjects with Mild and Episodic Cushing's Syndrome Suggests that the Paradigm for Diagnosis and Exclusion of Cushing's Syndrome Requires Multiple Testing
T. C. Friedman et al.
HORMONE AND METABOLIC RESEARCH (2010)
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Lucio Vilar et al.
PITUITARY (2010)
Effect of injectable bromocriptine in patients with Cushing's disease
C. Invitti et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
Treatment of Pituitary-Dependent Cushing's Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
M. Boscaro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Medical Treatment of Cushing's Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
Rosario Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement
B. M. K. Biller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The diagnosis of Cushing's syndrome: An endocrine society clinical practice guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome
Srividya Kidambi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Cyclic Cushing's syndrome: a clinical challenge
J. R. Meinardi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma
T Miyoshi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)
Nelson's syndrome: Complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment
LA Casulari et al.
HORMONE RESEARCH (2004)
Dopamine receptor expression and function in corticotroph pituitary tumors
R Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Dopamine as a prolactin (PRL) inhibitor
N Ben-Jonathan et al.
ENDOCRINE REVIEWS (2001)
ACTH silent adenoma shrinking under cabergoline
P Petrossians et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
The diagnosis of Cushing's syndrome -: Atypical presentations and laboratory shortcomings
M Boscaro et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
